Clinical Trial Update: FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

APhase 1/Phase 2 clinical trial evaluating FOLFOX with Bevacizumab and Hydroxychloroquine in colorectal cancer (rectal/colon cancer; includes metastasis and ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Adenocarcinoma
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Rectal Cancer, Colon Cancer | Phase 1, Phase 2 | Status: COMPLETED